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Abstract
Background: Multiple organ failure and early surgery are associated with high morbimortality after open
necrosectomy. Data are mostly derived from historical cohorts with early necrosectomy bereft of step-up treatment
algorithm implementation. Thus, mostly circumstantial evidence suggests a better clinical course following mini-
invasive surgical and endoscopic necrosectomy. We studied the results of open necrosectomy in a contemporary
cohort of patients with complicated pancreatic necrosis treated at a tertiary center.
Methods: A retrospective cohort study from a university teaching hospital. Results of 109 consecutive patients
treated with open necrosectomy during a 12-year period are reported.
Results: The overall 90-day mortality rate was 22.9%. The 90-day mortality rate was 10.6% if necrosectomy could be
delayed until 4 weeks from symptom onset and the necrosis had become walled off on preoperative imaging. The
risk factors for 90-day mortality were age over 60 years (OR 19.4), pre-existing co-morbidities (OR 16.9),
necrosectomy within 4 weeks (OR 6.5), multiple organ failure (OR 12.2), white blood cell count over 23 × 109 (OR
21.4), and deterioration or prolonged organ failure as an indication for necrosectomy (OR 10.4). None or one of
these risk factors was present in 52 patients (47.7% of all patients), and these patients had no mortality.
Conclusion: Late open necrosectomy for walled-off necrosis has a low mortality risk. Open necrosectomy can be
done without mortality in the absence of multiple risk factors for surgery.
Keywords: Necrosectomy, Open necrosectomy, Pancreatic necrosis, Walled-off necrosis, Infected pancreatic
necrosis, Pancreatitis, Acute pancreatitis, Severe acute pancreatitis, Mortality, Organ failure
Background
Most patients with severe acute pancreatitis suffer from
necrotizing pancreatitis, defined by the presence of
(peri)pancreatic necrosis on computed tomography (CT)
[1–3]. Infected pancreatic necrosis is associated with in-
creased mortality risk and will mostly require invasive
interventions [3–5]. A step-up management strategy
should be implemented, whereby only patients with
treatment failure after percutaneous or endoscopic
drainage should be considered for debridement of nec-
rotic tissue (necrosectomy) [6, 7]. All interventions
should be postponed until 4 weeks into the disease
whenever possible [6, 7].
Mortality rate after open necrosectomy varies between
8.8% and 22% in contemporary series [8–12]. Recent
meta-analyses suggest similar short-term mortality in
minimally invasive and open necrosectomy. However,
open necrosectomy might be associated with increased
adverse events and postoperative organ failure compared
with minimally invasive necrosectomy, although the
quality of evidence is low [13, 14]. Aspiration to alleviate
surgical stress and minimize morbidity related to open
necrosectomy has led to the development of less invasive
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debridement techniques. Minimally invasive necrosect-
omy is associated with an increased number of procedures
relative to open necrosectomy [12]. Open necrosectomy
provides thorough debridement in a single procedure,
which may be advantageous especially in widespread ne-
crosis. In patients who fail to improve or suffer complica-
tions after mini-invasive management of necrosis, open
necrosectomy provides a bail-out treatment option. Based
on recently published World Society of Emergency Sur-
gery guidelines for the management of severe acute pan-
creatitis, open necrosectomy is still a valid treatment
option for complicated pancreatic necrosis following a
step-up treatment scheme [7]
The aim of this study was to determine mortality and
morbidity risk factors following open necrosectomy in a
contemporary cohort of patients.
Methods
The study design was a retrospective analysis of all pa-
tients undergoing open surgical necrosectomy at
Helsinki University Hospital (Meilahti Hospital) between
1 January 2006 and 31 December 2017. Meilahti Hos-
pital, with a catchment population of 1.4 million, is a
secondary and tertiary surgical referral center respon-
sible for the majority of surgical necrosectomies in the
capital area of Helsinki. Patients were identified from the
database of surgical operations with ICD-10 diagnosis
code K85.X and NOMESCO classification of surgical
procedures code JLC50, which are used for pancreatic
necrosectomy. Also, all patients with acute pancreatitis
who were treated longer than 10 days or who had died
within the treatment period were manually checked for
potential necrosectomy. Data were collected from elec-
tronic hospital records, operation reports, laboratory
sheets, and the radiological imaging database (Agfa
IMPAX 6.6.1.5551). Severity of pancreatitis was classified
according to the Revised Atlanta Classification of Pan-
creatitis Severity [2]. Radiological imaging prior to the
first necrosectomy of all patients was re-evaluated by a
radiologist (JK). The collected data included all interven-
tions prior to the first necrosectomy from onset of dis-
ease, patient demographics, and other clinically relevant
data. Patients were treated at the intensive care unit
and/or surgical ward during their illness. Meilahti Hos-
pital intensive care unit is administered by intensivists,
but surgeons participate in the daily decision-making for
pancreatitis patients. The first open surgical necrosect-
omy, i.e., debridement of pancreatic and/or peripancrea-
tic necrotic tissue, serves as the index operation.
Classification and assessment of risk factors are based
on this index operation.
Positive bacterial culture from fine-needle aspiration or
drainage of pancreatic necrosis or gas on CT scan in nec-
rotic collection was considered a preoperative verification
of infected pancreatic necrosis. Preoperative suspicion of
infected pancreatic necrosis was based on clinicians’ judg-
ment. Usually, clinicians’ suspicion arose in the event of
elevated infectious laboratory parameters, new onset fever,
or new onset organ failure at a later stage of the disease. If
infected pancreatic necrosis was suspected, but could not
be confirmed preoperatively, the microbiological samples
taken from the pancreatic necrosis at the index operation
determined whether or not the patient had infected pan-
creatic necrosis.
The method of choice at our center was mainly open
necrosectomy. Although some endoscopic procedures and
selected patients were treated with only percutaneous
drainage of necrosis, these patients were not included in
this study. Step-up methodology was implemented in-
creasingly towards the latter part of the study period. Pa-
tients without preceding drainage were deteriorating, had
a verified or suspected intra-abdominal emergency (e.g.,
bowel perforation or ischemia), were treated with open
abdomen, did not have a safe percutaneous drainage route
to the necrotic collection, or had widespread necrosis. The
decision for surgical debridement was made by a multidis-
ciplinary team with anaesthesiologists and presiding
acute-care gastrointestinal surgeons.
A disconnected left pancreatic remnant on CT scan
was defined according to Sandrasegaran et al. [15],
meaning a large intrapancreatic non-enhancement com-
bined with a viable segment of the distal body or tail of
the pancreas. Data on all reoperations within 6months
of the index operation and endoscopic interventions up
to 1 year were collected. If the patient survived to dis-
charge, information on survival was retrieved from the
Finnish Civil Registry. The STROBE statement was
followed (www.strobe-statement.org).
Surgical technique
Operations were mainly performed via upper transverse
subcostal laparotomy because it provides good exposure
to affected necrotic areas. However, midline laparotomy
was used selectively in patients who have had laparost-
omy for treatment of abdominal compartment syndrome
or in cases where bowel resection was anticipated. Pan-
creatic and peripancreatic necrosis was approached
through the gastrocolic ligament. Necrosectomy was
done using blunt manual dissection assisted with careful
suction to avoid trauma to vital tissues. Microbiological
samples from necrotic tissue were taken routinely during
the operation. In cases where retrocolic or retromesen-
teric necrosis was present, these areas were approached
lateral to the ascending or descending colon with or
without mobilization of the hepatic flexure or splenic
flexure, respectively. To decrease the risk of iatrogenic
colonic injury, the mobilization of the colonic flexures
was done only if it was deemed necessary for the
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debridement procedure. After debridement of all necro-
sis, lavage with normal saline was done. One to four Ch
24 silicone drains were left in place depending on the
extent of the necrosis. A retroperitoneal route from
flanks was used for the drains. Postoperative lavage was
not used. In addition to necrosectomy, a disconnected
left pancreatic remnant was resected, and a cholecystec-
tomy was performed on patients with biliary pancreatitis
during the index necrosectomy unless the patient was in
poor condition. In addition, resection of necrotic or per-
forated bowel was done as needed. Open abdomen with
vacuum-assisted closure after the operation was used
only if closure of the abdomen was not possible.
Statistical analysis
Statistical analysis was performed using SPSS 24.0 (IBM
Corp., Armonk, NY, USA) and STATA 13.1 (StataCorp,
College Station, TX, USA). Univariate odds ratios (ORs)
with 95% confidence interval (CI) were calculated, and
univariate logistic regression was used. Statistical testing
of proportions was calculated using two-sided Fisher’s
exact test and differences in continuous variables using
Mann-Whitney U test. Receiver operating characteristic
curve was used to define optimal cutoff points of con-
tinuous variables. Chi-square with linear-by-linear asso-
ciation test was utilized to calculate linear relationships.
A multivariable logistic regression analysis based on uni-
variate analysis of preoperatively available risk factors (P
< 0.010) was performed. Multivariable logistic regression
with stepwise forward method was used and goodness of
fit of the regression model was tested with the Hosmer-
Lemeshow test.
Results
A systematic search of the database of surgical opera-
tions yielded 116 patients. A review of patient records
revealed that three patients had procedures other than
necrosectomy, three patients had the first necrosectomy
done at another hospital, and one patient underwent
laparoscopic necrosectomy; these seven patients were
excluded from the study. Thus, 109 patients with pri-
mary open surgical necrosectomy for pancreatic necrosis
were included in this study.
Patient characteristics
Patient characteristics are summarized in Table 1. Of
the 109 patients, 70 (64.2%) suffered from severe and 39
(35.8%) from moderately severe acute pancreatitis. At
the time of the index necrosectomy, 44 patients (40.4%)
were treated at the intensive care unit. The necrotic col-
lection had become walled off in 91 patients (83.5%),
whereas 18 patients (16.5%) suffered from acute necrotic
collections according to preoperative CT. Twelve pa-
tients (11.0%) had single organ failure and 33 (30.3%)
multiple organ failure within 24 h of necrosectomy. Pre-
ceding open abdomen treatment for abdominal com-
partment syndrome was necessary in 21 patients
(19.3%). One of four acute care gastrointestinal surgeons
performed the index operation on 94 patients (86.2%).
The indication for necrosectomy was verified or sus-
pected infected pancreatic necrosis in 82 patients
(75.2%). Prolonged organ failure and/or deterioration of
existing organ failures was the indication in 18 patients
(16.5%). Six patients (5.5%) had necrosectomy due to
prolonged pain and three patients (2.8%) due to bleed-
ing, persistent gastric outlet obstruction symptoms, and
suspicion of colonic necrosis. Ten patients (25.6%) be-
tween the years 2006 and 2011 and 30 patients (42.9%)
between the years 2012 and 2017 were treated according
to the step-up approach (P = 0.098). Within the study
period, the annual proportion of patients undergoing
step-up treatment increased significantly (P = 0.013).
In 98 patients (89.9%), the necrosis extended to either
the paracolic gutter or the retromesenteric area. Sixty-
six patients (60.6%) had necrosis in both paracolic gut-
ters or one of the paracolic gutters and the retromesen-
teric area, which was defined as complex necrosis. A
disconnected left pancreatic remnant was present in 40
patients (36.7%) on preoperative imaging or as an intra-
operative finding at the index necrosectomy. Sixteen
(40.0%) of these patients (11 simultaneously with the
index necrosectomy) were treated with a pancreatic re-
section within 6 months. Pancreatico- or fistulojejunost-
omy was performed on 4 (10.0%) of 40 patients with a
disconnected left pancreatic remnant. Endoscopic stent-
ing of the pancreatic duct following open necrosectomy
was performed on 15 patients (37.5%) with a discon-
nected left pancreatic remnant. Pancreatic fistula follow-
ing necrosectomy was observed in 43 patients (39.4%),
significantly more often in patients with a disconnected
left pancreatic remnant on preoperative CT scan (P =
0.007). Simultaneously with the first necrosectomy, 20
cholecystectomies, 7 bowel resections, 7 splenectomies,
and 12 pancreatic resections were performed. Synchron-
ous cholecystectomy with the index operation was per-
formed on 15 patients (60%) with biliary pancreatitis.
Risk of infected pancreatic necrosis
Pancreatic necrosis was infected in 85 patients (78.0%).
The probability for infected pancreatic necrosis was
higher when necrosectomy was done after 4 weeks from
symptom onset than when necrosectomy was performed
within the first 4 weeks (P = 0.017). All patients with
open abdomen before the first necrosectomy developed
infected pancreatic necrosis, whereas 64 patients (72.7%)
without antecedent open abdomen treatment developed
infected pancreatic necrosis (P = 0.006).
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Postoperative organ failure
A new onset organ failure within 1 week following the
index operation occurred in 38 patients (34.9%). In 15
patients (13.8%), the organ failure was transient, resolv-
ing within 48 h, whereas 23 patients (21.1%) had a new
persistent organ failure that did not resolve within 48 h.
No association emerged between new onset organ failure
and 90-day mortality (Table 2). A total of seven organ
failures recorded before the first necrosectomy (in five
different patients) resolved within 48 h of the first
necrosectomy.
Renecrosectomies and other reoperations
Indications and reoperations are presented in Additional
file 1. Overall, 52 patients (47.7%) had a reoperation, and
27 patients (24.8%) had a renecrosectomy within 6
months of the index operation. Twenty-seven (67.5%) of
40 patients needed at least one additional operation
(renecrosectomy or other) if the first necrosectomy was
within 28 days of symptom debut, whereas 25 (36.2%) of
69 patients required an additional operation if necrosect-
omy could be postponed for more than 28 days (P =
0.003). Complex necrosis increased the risk of any reop-
eration, as 38 patients (57.6%) with complex necrosis
underwent a reoperation compared with 14 patients
(32.6%) without complex necrosis (P = 0.012).
Median period from symptom onset to the first necro-
sectomy was 40 days (interquartile range, IQR, 25–67) if
patients underwent one, and 25 days (IQR 19-36) if pa-
tients underwent more than one necrosectomy (P =
0.006). First necrosectomy within 28 days (OR 3.52, 95%
CI 1.43–8.67, P = 0.010), open abdomen at the time of
index necrosectomy (OR 11.47, 95% CI 3.21–40.96, P <
0.001), postoperative open abdomen treatment (OR 8.07,
95% CI 3.00–21.71, P < 0.001), preceding multiple organ
failure (OR 7.01, 95% CI 2.70–18.19, P < 0.001), and se-
vere acute pancreatitis at the time of the first necrosect-
omy (OR 3.12, 95% CI 1.07–9.05, P = 0.038) were
associated with the need for repeat necrosectomies.
Other reoperations were performed on 42 patients
(38.5%). The need for reoperations was associated with
the need for renecrosectomies (P = 0.006). Index necro-
sectomy due to acute necrotic collections increased the
Table 1 Patient characteristics at index necrosectomy
(n = 109)
Age at onset of symptoms, median (IQR), years 52 (42–61)
Time from onset of symptoms, median (IQR), days 36 (22–59)
< 28 days from symptom onset 40 (36.7%)
Length of stay at intensive care unit, median (IQR),
days
15 (1–24)
Male sex 96 (88.1%)
Co-morbidities
Heart disease 22 (20.2%)
Pulmonary disease 10 (9.2%)
Mild renal insufficiency 4 (3.7%)
Diabetes 11 (10.1%)
Liver cirrhosis 2 (1.8%)
Chronic pancreatitis 3 (2.8%)
None of the above 66 (60.6%)
Etiology
Alcohol 62 (56.9%)
Biliary 25 (22.9%)
Idiopathic 11 (10.1%)
Other* 11 (10.1%)
Preoperative computed tomography
Pancreatic necrosis
Not assessable 45 (41.3%)
< 30% 31 (28.4%)
30–50% 11 (10.1%)
> 50% 22 (20.2%)
Distant pancreatic necrosis† 98 (89.9%)
Complex necrosis‡ 66 (60.6%)
Disconnected left pancreatic remnant 34 (31.2%)
Previous organ failure
No organ failure 32 (29.4%)
< 48 h organ failure 7 (6.4%)
> 48 h organ failure 70 (64.2%)
Previous interventions of necrosis
Fine-needle aspiration 31 (28.4%)
Percutaneous drainage 28 (25.7%)
Endoscopic drainage§ 7 (6.4%)
Surgical drainage|| 11 (10.1%)
Drainage duration, median (IQR), days¶ 9 (6–14)
CRP, median (IQR)# 167 (89–290)
WBC count, median (IQR)# 12.6 (9.4–
21.3)
Intra-operative findings
Infected pancreatic necrosis 85 (78.0%)
Disconnected left pancreatic remnant 13 (11.9%)
Resection of pancreas during index necrosectomy 12 (11.0%)
IQR interquartile range, CRP C-reactive protein, WBC white blood cell
*Other: post-ERCP (6), postoperative (2), post-endoscopic (1),
hypertriglyceridemia (1) and drug-induced (1)
†Local necrosis around pancreas, distant necrosis also in left/right paracolic
gutter and/or retromesenteric area
‡Necrosis extending to both paracolic gutters or either of the paracolic gutters
and the retromesenteric area
§Pseudocyst gastrostomy or transpapillary canalization
||Surgical canalization of necrosis in patients with existing abdomen treatment
¶Percutaneous or surgically placed drainage
#Within 24 h of index necrosectomy. CRP expressed as mg/L. WBC count
expressed as 1 × 109/L. Two CRP values and one WBC count were not taken
24 h prior to operation, and thus, the last available CRP value and WBC count
prior to first necrosectomy, respectively, was used
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risk for a reoperation due to bleeding compared with
necrosectomy for walled-off necrosis (P = 0.002). Nine
patients (8.3%) needed a second operation for the treat-
ment of pancreatic fistula.
Ninety-day mortality after necrosectomy
Overall, 25 patients (22.9%) died within 90 days of the
first necrosectomy (Fig. 1). The median age at disease
onset was 50 years (IQR 40–59) in survivors and 61 years
(52–67) in non-survivors (P = 0.002). Age over 60 years,
necrosectomy within 28 days, acute necrotic collections,
multiple organ failure, preoperative white blood cell
(WBC) count over 23 × 109, deterioration or prolonged
organ failure as an indication for necrosectomy, and
leaving pancreatic necrosis during necrosectomy were
associated with increased mortality in univariate analysis
(Additional file 2). When necrosectomy for walled-off
necrosis could be delayed until 4 weeks after onset of
symptoms, 7 (10.6%) of 66 patients died, whereas 8
(32.0%) of 25 patients died if necrosectomy was carried
out earlier (P = 0.024). Postoperative risk factors for
death are summarized in Table 2.
Independent risk factors for 90-day mortality were age
over 60 years, any co-morbidity, deterioration or prolonged
Table 2 Postoperative predictors of mortality
Risk factor Survivors (n = 84)* Non-survivors (n = 25)* OR (95% CI) P
New onset organ failure 26 (31.0%) 12 (48.0%) 2.059 (0.828–5.120) 0.152
Persistent organ failure 15 (17.9%) 8 (32.0%) 2.165 (0.789–5.937) 0.163
Multiple necrosectomies 18 (21.4%) 9 (36.0%) 2.063 (0.783–5.434) 0.186
Other reoperations 27 (32.1%) 15 (60.0%) 3.167 (1.260–7.961) 0.018
Postoperative bleeding† 3 (3.6%) 8 (32.0%) 12.706 (3.052–52.893) < 0.001
Enteric fistula or intestinal ischaemia‡ 10 (11.9%) 10 (40.0%) 4.933 (1.748–13.922) < 0.003
Postoperative open abdomen 12 (14.3%) 14 (56.0%) 7.636 (2.813–20.728) < 0.001
*Percentage in parentheses is % of survivors/non-survivors
†Reoperation due to postoperative bleeding
‡Indication for reoperation: verified or suspected enteric fistula or intestinal ischemia
Fig. 1 Kaplan-Meier 90-day survival table, walled-off necrosis vs. acute necrotic collections
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organ failure as the indication for necrosectomy, necrosect-
omy within 28 days of symptom onset, multiple organ fail-
ure at the time of necrosectomy, and WBC count over 23
× 109 (Table 3). Based on the result of multivariate analysis,
the effects of different risk factor combinations on 90-day
mortality were calculated. As shown in Table 4, any com-
bination of these six risk factors increased the mortality
rate to at least 50%, whereas in 52 patients who had no
more than one risk factor, the mortality rate was 0%.
Discussion
This study shows that mortality after open necrosectomy
depends on patients’ preoperative risk factors. Preopera-
tive risk factors for open necrosectomy were age over 60
years, pre-existing co-morbidities, necrosectomy within 4
weeks, multiple organ failure, white blood cell (WBC)
count over 23 × 109, and deterioration or prolonged organ
failure as an indication for necrosectomy. The absence of
specified risk factor combinations facilitates open necro-
sectomy without mortality. On the other hand, mortality
risk is high when these risk factor combinations are
present. We showed that the indication for open necro-
sectomy is associated with mortality, and that mortality
risk increased if patients were deteriorating or when pa-
tients did not have clinical improvement of organ failures
preceding open necrosectomy. We report that the mortal-
ity rate after open necrosectomy for walled-off necrosis is
around 10% if the procedure can be postponed for the first
28 days.
Our study shows that patients without multiple risk
factors for surgery have excellent results after open
necrosectomy, as there was no mortality in this sub-
group of patients. Consequently, diminishing these pre-
operative risk factors will improve outcome. From a
practical standpoint, the only risk factors that could be
manipulated are timing and indication for surgery. In
Table 3 Ninety-day survival, forward conditional multivariate analysis
Risk factor OR (95% CI) P
Age > 60 years 19.355 (2.466–151.593) 0.005
Any co-morbidity* 16.869 (1.981–143.633) 0.010
Indication of necrosectomy: deterioration/prolonged organ failure 10.421 (1.572–69.080) 0.015
Necrosectomy < 28 days from symptom onset 6.480 (1.280–32.812) 0.024
Multiple organ failure† 12.159 (1.155–127.981) 0.038
Preoperative WBC count ≥ 23.0‡ 21.442 (3.162–145.392) 0.002
Cut-off value for entry into multivariate analysis was P < 0.010 in Additional file 2
CI confidence interval, WBC white blood cell
*Any of the comorbidities presented in univariate analysis of all patients (Additional file 2)
†At least two of the following organ failures within 24 h of first necrosectomy: Cardiovascular, respiratory or renal
‡WBC count expressed as 1 × 109/L. One WBC count was not taken 24 h prior to operation, and thus, the last available WBC count prior to first necrosectomy
was used
Table 4 Risk factor combinations and mortality
Age > 60 years Co-morbidity* Indication† Necrosectomy
< 28 days‡
Multiple organ
failure
WBC count
≥ 23.0§
No risk
factors||
Age > 60 years 41.9%, 31
Co-morbidity* 50.0%, 18 32.6%, 43
Indication† 85.7%, 7 50.0%, 6 66.7%, 18
Necrosectomy < 28 days‡ 61.5%, 13 60.0%, 15 88.9%, 9 42.5%, 40
Multiple organ failure 83.3%, 6 75.0%, 8 84.6%, 13 52.4%, 21 48.5%, 33
WBC count ≥ 23.0§ 100.0%, 6 80.0%, 10 88.9%, 9 76.9%, 13 68.8%, 16 62.5%, 24
No risk factors|| 0.0%, 6 0.0%, 11 0.0%, 2 0.0%, 5 0.0%, 2 0.0%, 2 0.0%, 24
Bolded values represent mortality percentage at 90-day follow up after first necrosectomy in patients with the specific risk factor combination in question. Non-
bolded values are the absolute number of patients with the specific risk combination in question
WBC white blood cell
*Any of the gathered co-morbidities in univariate analysis (Additional file 2)
†Indication of necrosectomy: deterioration/prolonged organ failure
‡From symptom onset
§WBC count expressed as 1 × 109/L. Within 24 h of first necrosectomy. One WBC count was not taken 24 h prior to operation, and thus, the last available WBC
count prior to first necrosectomy was used
||None of the risk factors presented in multivariate analysis (Table 3)
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line with treatment guidelines, open necrosectomy
should be postponed as long as possible—for at least the
first four weeks—if the patient can tolerate the compli-
cated pancreatitis [6, 7]. If multiple organ failure prevails
for weeks or the patient deteriorates despite maximal
supportive care, mortality after open surgery is high
when the patient has co-existing risk factors for open
necrosectomy. Whether a non-operative approach or
minimally invasive techniques would result in better out-
comes in these patients warrants investigation since
sparse data are available on their management.
Based on the current literature and our own experience,
we summarize recommendations for the use of open necro-
sectomy in a modern-day setting (Table 5). Open necro-
sectomy serves as a salvage technique for complications
following other interventions or the (peri)pancreatic necro-
sis itself and is a treatment option after treatment failure
following a minimally invasive step-up algorithm. An on-
going open abdomen treatment, the need for simultaneous
other resections (e.g., resection of a disconnected left pan-
creatic remnant), and available local expertise are other rea-
sons for use of the open necrosectomy technique.
The overall mortality rate reported in our study is in
line with recent reported cohorts of patients undergoing
open necrosectomy [8–11]. Consistent with previous
studies, our results indicate that age, multiple organ fail-
ure, and timing of intervention dramatically affect mor-
tality [10, 11, 16, 17]. An association between markedly
increased WBC count and death has earlier been shown
in studies of acute pancreatitis and severe acute pancrea-
titis [18–21].
There was significant morbidity in terms of a need for
additional operations after the first open necrosectomy.
However, all patients regardless of the complexity of ne-
crosis, timing of surgery, or indication for surgery were
included in this study. Around two-thirds of our patients
had complex necrosis (affecting both paracolic gutters or
the retromesenteric area and one of the paracolic gutters),
which was associated with the need for re-interventions.
We treated 14 patients with an ongoing open abdomen at
the time of the index operation, and one-third of all pa-
tients had multiple organ failure within 24 h of the first
necrosectomy; both of these factors were significantly as-
sociated with later morbidity in this study. Hence, it seems
that the severity of the disease and the extent of necrosis
probably increased the need for re-interventions. At least
in part due to the historical nature of this series, the first
necrosectomy was carried out within 28 days of symptom
debut in more than one-third of patients. As shown by
our research, early necrosectomy was significantly associ-
ated with the need for additional interventions.
The rate of postoperative pancreatic fistulas was com-
parable to previous studies on open and mini-invasive
surgical necrosectomy and clearly higher than after endo-
scopic or transgastric open surgical necrosectomy [8, 22,
23]. On the other hand, our study showed that only a mi-
nority of patients with postoperative pancreatic fistulas
needed an additional operation, and most patients could
be treated by endoscopic stenting. In the context of open
surgery, open transgastric necrosectomy seems to be a
beneficial strategy to tackle the high incidence of pancrea-
ticocutaneous fistulation after open surgery and might re-
duce the need for resection of the tail of the pancreas after
a disconnected left pancreatic remnant [22].
One-quarter of all patients required a median of one
additional necrosectomy. Conversely, 75% of patients
had no need for repeat necrosectomy, which is in accord
with previous studies [8, 9]. Mini-invasive techniques,
such as video-assisted retroperitoneal debridement and
endoscopic necrosectomy, are associated with the need
for repeat debridement procedures due to insufficient
initial debridement [24, 25] Open necrosectomy prob-
ably facilitates the most complete debridement of pan-
creatic necrosis in a single procedure. Interestingly, our
results indicate that failure to fully debride necrosis is a
significant risk factor for death, and hence, a minimally
invasive repeat debridement strategy might be disadvan-
tageous in patients with widespread necrosis.
During the study period percutaneous drainage was
not extensively used. We implemented step-up manage-
ment to postpone surgical intervention when the nec-
rotic collection had not matured and if there was
suspicion of infected pancreatic necrosis with a diagnos-
tic and therapeutic intention. In case of clinical deterior-
ation of the patient or when an abdominal catastrophe
was suspected or verified, primary open necrosectomy
was employed. The publication of the PANTER trial of
step-up mini-invasive necrosectomy in 2010 is seemingly
reflected in our results as an increased use of percutan-
eous drainage towards the latter years of our study
period [8]. However, most patients in our study suffered
from complex pancreatic necrosis, which has been asso-
ciated with drainage treatment failure in previous studies
[26].
Table 5 Situations in which open necrosectomy is a valid
option for treatment of infected pancreatic necrosis
Treatment failure or complication (e.g., persistent bleeding after
attempted endovascular treatment) after step-up management
procedure
Bowel ischemia or perforation (suspected/verified) due to necrosis
Ongoing open abdomen with simultaneous indication for
necrosectomy
Disconnected left pancreatic remnant fueling the disease
Insufficient experience or equipment for mini-invasive necrosectomy
Biliary pancreatitis with simultaneous need for cholecystectomy
Anatomically widespread necrosis
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This study has several limitations. The retrospective
setting, in which the indications and timing for surgery
were not controlled, may introduce a bias to the range
of patients treated. However, in contrast to several other
reports regarding open, mini-invasive, and endoscopic
necrosectomies, we included the whole spectrum of pa-
tients treated at our institution, including the most se-
vere cases with preceding open abdomen treatment for
abdominal compartment syndrome. Most patients had a
widespread necrosis affecting beyond the area around
the pancreas, and a disconnected left pancreatic remnant
was radiologically evaluated to be present in about one-
third of cases. Both of these factors reflect the severity of
disease treated in this cohort. Also, the annual number
of necrosectomies in this cohort was fairly low, aver-
aging 9 cases a year over the 12-year study period, which
would computationally account for less than 5% of pa-
tients with acute pancreatitis [1]. It therefore seems un-
likely that the threshold for surgery was too low at our
center. Due to the inherent nature of the retrospective
setting of this study, we cannot rule out unknown con-
founding factors, e.g., utilization of intensive care unit
treatment. However, we are not aware of any significant
other management changes, such as availability of inten-
sive care unit treatment, during the study period. An-
other limitation is that organ-specific severity was not
evaluated systematically from the cohort, which would
have shed more light on the severity of disease at the
time of surgery, albeit around 40% of patients had single
or multiple organ failure at the time of surgery. Further-
more, although a clinical follow-up visit for the patients
was arranged, there was no specific or pre-adjusted
schema for these outpatient controls, and thus, informa-
tion regarding, for example, hernia occurrence, use of
pancreatic enzymes, rate of new onset diabetes, and
measures of quality of life is lacking.
Conclusion
Open necrosectomy is a viable treatment in selected pa-
tients with complicated pancreatic necrosis. Patients
with walled-off necrosis who are treated with open
necrosectomy after 28 days from disease onset have
around 10% mortality. Mortality is higher than 50%
when multiple risk factors for open necrosectomy are
present. Without these multiple risk factors, open necro-
sectomy can be done without mortality.
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